2024. Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by blue light in the treatment of facial cutaneous squamous cell carcinoma in situ. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s483. DOI:https://doi.org/10.25251/skin.8.supp.483.